GlaxoSmithKline PLC Director/PDMR Shareholding

Date : 06/13/2019 @ 12:10AM
Source : UK Regulatory (RNS & others)
Stock : Glaxosmithkline Plc (GSK)
Quote : 1713.6  13.8 (0.81%) @ 11:04PM
Glaxosmithkline share price Chart

GlaxoSmithKline PLC Director/PDMR Shareholding

Glaxosmithkline (LSE:GSK)
Historical Stock Chart

6 Months : From May 2019 to Nov 2019

Click Here for more Glaxosmithkline Charts.

TIDMGSK

RNS Number : 0220C

GlaxoSmithKline PLC

12 June 2019

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ===================================================================== 
 a)   Name                     Ms E Walmsley 
===  ========================  =========================================== 
 b)   Position/status          Chief Executive Officer 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the             Acquisition of Ordinary Shares under the 
       transaction               Company's Share Reward Plan. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                  GBP15.8480   7 (partnership shares) 
                                              ----------------------- 
                                  GBP15.8480   7 (matching shares) 
                                              ----------------------- 
===  ========================  =========================================== 
 d)   Aggregated information 
       Aggregated volume 
       Price 
 
                                 14 Ordinary Shares 
                                 GBP15.8480 
===  ========================  =========================================== 
 e)   Date of the transaction  2019-06-11 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Mr R G Connor 
===  ========================  ============================================ 
 b)   Position/status          President, Global Vaccines 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the             Acquisition of Ordinary Shares under the 
       transaction               Company's Share Reward Plan. 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                  GBP15.8480   8 (partnership shares) 
                                              ----------------------- 
                                  GBP15.8480   8 (matching shares) 
                                              ----------------------- 
===  ========================  ============================================ 
 d)   Aggregated information 
       Aggregated volume 
       Price 
 
                                 16 Ordinary Shares 
                                 GBP15.8480 
===  ========================  ============================================ 
 e)   Date of the transaction  2019-06-11 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ===================================================================== 
 a)   Name                     Mr N Hirons 
===  ========================  =========================================== 
 b)   Position/status          SVP, Global Ethics and Compliance 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the             Acquisition of Ordinary Shares under the 
       transaction               Company's Share Reward Plan. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                  GBP15.8480   8 (partnership shares) 
                                              ----------------------- 
                                  GBP15.8480   8 (matching shares) 
                                              ----------------------- 
===  ========================  =========================================== 
 d)   Aggregated information 
       Aggregated volume 
       Price 
 
                                 16 Ordinary Shares 
                                 GBP15.8480 
===  ========================  =========================================== 
 e)   Date of the transaction  2019-06-11 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Ms S Jackson 
===  ========================  ============================================ 
 b)   Position/status          SVP, Global Communications and CEO Office 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the             Acquisition of Ordinary Shares under the 
       transaction               Company's Share Reward Plan. 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                  GBP15.8480   8 (partnership shares) 
                                              ----------------------- 
                                  GBP15.8480   8 (matching shares) 
                                              ----------------------- 
===  ========================  ============================================ 
 d)   Aggregated information 
       Aggregated volume 
       Price 
 
                                 16 Ordinary Shares 
                                 GBP15.8480 
===  ========================  ============================================ 
 e)   Date of the transaction  2019-06-11 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ========================================================================= 
 a)   Name                     Mr D Jackson 
===  ========================  =============================================== 
 b)   Position/status          PCA of Ms S Jackson (SVP, Global Communications 
                                and CEO Office) 
===  ========================  =============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================= 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  =============================================== 
 b)   Nature of the             Acquisition of Ordinary Shares under the 
       transaction               Company's Share Reward Plan. 
===  ========================  =============================================== 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                  GBP15.8480   8 (partnership shares) 
                                              ----------------------- 
                                  GBP15.8480   8 (matching shares) 
                                              ----------------------- 
===  ========================  =============================================== 
 d)   Aggregated information 
       Aggregated volume 
       Price 
 
                                 16 Ordinary Shares 
                                 GBP15.8480 
===  ========================  =============================================== 
 e)   Date of the transaction  2019-06-11 
===  ========================  =============================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =============================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Mr D S Redfern 
===  ========================  ============================================ 
 b)   Position/status          Chief Strategy Officer 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the             Acquisition of Ordinary Shares under the 
       transaction               Company's Share Reward Plan. 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                  GBP15.8480   7 (partnership shares) 
                                              ----------------------- 
                                  GBP15.8480   7 (matching shares) 
                                              ----------------------- 
===  ========================  ============================================ 
 d)   Aggregated information 
       Aggregated volume 
       Price 
 
                                 14 Ordinary Shares 
                                 GBP15.8480 
===  ========================  ============================================ 
 e)   Date of the transaction  2019-06-11 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Mr R Simard 
===  ========================  ============================================ 
 b)   Position/status          President, Pharma Supply Chain 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the             Acquisition of Ordinary Shares under the 
       transaction               Company's Share Reward Plan. 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                  GBP15.8480   8 (partnership shares) 
                                              ----------------------- 
                                  GBP15.8480   8 (matching shares) 
                                              ----------------------- 
===  ========================  ============================================ 
 d)   Aggregated information 
       Aggregated volume 
       Price 
 
                                 16 Ordinary Shares 
                                 GBP15.8480 
===  ========================  ============================================ 
 e)   Date of the transaction  2019-06-11 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Mr P C Thomson 
===  ========================  ============================================ 
 b)   Position/status          President, Global Affairs 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the             Acquisition of Ordinary Shares under the 
       transaction               Company's Share Reward Plan. 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                  GBP15.8480   8 (partnership shares) 
                                              ----------------------- 
                                  GBP15.8480   8 (matching shares) 
                                              ----------------------- 
===  ========================  ============================================ 
 d)   Aggregated information 
       Aggregated volume 
       Price 
 
                                 16 Ordinary Shares 
                                 GBP15.8480 
===  ========================  ============================================ 
 e)   Date of the transaction  2019-06-11 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Mrs V A Whyte 
===  ========================  ============================================ 
 b)   Position/status          Company Secretary 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the             Acquisition of Ordinary Shares under the 
       transaction               Company's Share Reward Plan. 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                  GBP15.8480   8 (partnership shares) 
                                              ----------------------- 
                                  GBP15.8480   8 (matching shares) 
                                              ----------------------- 
===  ========================  ============================================ 
 d)   Aggregated information 
       Aggregated volume 
       Price 
 
                                 16 Ordinary Shares 
                                 GBP15.8480 
===  ========================  ============================================ 
 e)   Date of the transaction  2019-06-11 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHQLLFFKQFBBBB

(END) Dow Jones Newswires

June 12, 2019 12:10 ET (16:10 GMT)

Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

Finance Manila is owned and operated by ADVFN PLC.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:fm D:20191118 15:19:42